"With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need." According to Eli Lilly, adults in the Phase 3 trials all lost weight with orforglipron and on the highest dose of 36 mg of orforglipron, the trial participants lost about 27 pounds over the course of 72 weeks or about 12% of their body weight, which is meaningful but not quite as high as some injectables
In these situations, it is beneficial to discuss with individuals whether this is related to disordered thoughts about food as love, affective changes induced by the medication, or a loss of interest in a food-related hobby such as cooking [148]
On Monday, the United Nations health agency issued its first guidelines on how such drugs could be used as a key tool for treating obesity in adults as a chronic, relapsing disease
RSI: rapid sequence induction PRACTICAL RECOMMENDATIONS Clinicians should be aware of the potential perioperative risk in patients receiving GLP-1RAs, GIP/ GLP-1RA and SGLT2 inhibitors
This is a crucial factor we consider when prescribing medication
Pi-Sunyer X, Astrup A, Fujioka K et al